Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Stereotactic Body Radiotherapy
•
Prostate Cancer
What fractionation and dose constraints do you use for prostate SBRT?
Answer from: Radiation Oncologist at Community Practice
UCLA King Protocol8 Gy x5PTV 95% of PTV volume to get 95-110% rx doseRectum V50 (20 Gy) < 50%V80 (32 Gy) < 20%V90 (36 Gy) < 10 %V100 (40Gy) < 5%BladderV50 (20 Gy) < 40%V100 (40 Gy) < 1.1%Femurs V40 (16 Gy) < 5%Small Bowel V50 (20Gy) < 1%
Sign in or Register to read more
380
Related Questions
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
In asymptomatic patients with castrate resistant prostate cancer who have failed chemotherapy and have progressive vertebral body metastases, when do you prescribe lutetium-177 vs prophylactic spinal radiation?
Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?
How do you reconcile discordant PSMA and MRI findings in patients undergoing definitive radiotherapy for prostate cancer?
Which patients with prostate cancer do you consider to be good candidates for salvage local treatment after radiation therapy?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Would you offer salvage radiation for a local recurrence of prostate cancer that was initially treated with SBRT?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?